<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00140829</url>
  </required_header>
  <id_info>
    <org_study_id>RBM01-29</org_study_id>
    <secondary_id>DGS2005/003</secondary_id>
    <nct_id>NCT00140829</nct_id>
  </id_info>
  <brief_title>SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias</brief_title>
  <acronym>Spatax</acronym>
  <official_title>Clinical and Genetic Analysis of Autosomal Recessive Forms of Cerebellar Ataxias and Spastic Paraplegias</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut des Maladies Rares</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Research Agency, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cerebellar ataxias (CA) and spastic paraplegias (SP) are genetically and clinically very
      heterogeneous. More than 40 loci are already known but the number of phenotypes is even
      greater suggesting further genetic heterogeneity. These progressive disorders are often
      severe and fatal, due to the absence of specific therapy. The SPATAX network combines the
      experience of European clinicians and scientists working on these groups of diseases. Over
      the past year, they have assembled the largest collection of families and achieved a number
      of tasks (initiation of a clinical and genetic database, distribution of DNA to participating
      laboratories, mapping of three new loci, and refinement of several loci). In addition to
      clinicians from Europe and Mediterranean countries, who play a major role in collecting
      families according to evaluation tools developed and validated by the SPATAX members, the
      group includes major European laboratories devoted to the elucidation of the molecular basis
      of these disorders. Each laboratory will centralize all families with a subtype of autosomal
      recessive (AR) CA (n=116) or SP (n=207) in order to efficiently map and identify the
      responsible gene(s). Genome-wide scans are already underway in 61 families. Given the
      expertise of the participants, the researchers expect to map and identify several genes
      during the course of this project. The spectrum of mutations and phenotype/genotype
      correlations will be analysed thanks to this unique series of patients with various
      phenotypes. The knowledge gained will be immediately applicable to patients in terms of
      improved positive diagnosis, follow-up and appropriate genetic counselling. In the long term,
      models for genetic entity will be developed in order to understand the pathophysiology and to
      identify new targets for treatment. The series of patients assembled and the precise
      knowledge of natural history will facilitate the implantation of therapeutic trials based on
      rational approaches.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2003</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">6000</enrollment>
  <condition>Cerebellar Ataxias</condition>
  <condition>Spastic Paraplegias</condition>
  <eligibility>
    <study_pop>
      <textblock>
        French population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Progressive ataxia or paraplegia

        Exclusion Criteria:

          -  Lack of signed informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandra Dürr, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alessandro Filla, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federico II University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>André Mégarbané, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université Saint-Joseph</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ali Benomar, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Rabat</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christophe Verny, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Angers</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Didier Hannequin, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux de Rouen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Diana Rodriguez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Enrico Bertini, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università de Roma</affiliation>
  </overall_official>
  <overall_official>
    <last_name>François Tison, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux de Bordeaux</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jorgen E Nielsen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Panum Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mustapha Salih, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>College of Medicine and KKUH</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Miriem Tazir, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université d'Alger</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nicholas W Wood, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Neurology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Odile Boespflug-Tanguy, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux de Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Philippe Azulay, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paula Coutinho, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade do Porto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre Labauge, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux de Nîmes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre Pollak, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux de Grenoble</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas T Warner, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University College, London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexander Lossos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah-Hebrew University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cyril Goizet, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Pellegrin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick Calvas, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Purpan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Berry Kremer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vladimir Kostic, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Centre of Serbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chokri Mhiri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Habib Bourguiba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Massimo Pandolfo, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université Libre de Bruxelles - Hôpital Erasme</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jorge Sequeiros, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade do Porto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chantal ME Tallaksen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ullevaal University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexandra Dürr, MD, PhD</last_name>
    <phone>00331 57 27 46 82</phone>
    <email>alexandra.durr@upmc.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Mustapha</name>
      <address>
        <city>Algiers</city>
        <zip>16000</zip>
        <country>Algeria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miriem Tazir, MD, PhD</last_name>
      <phone>0021321235640</phone>
      <email>meriemtazir@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Miriem Tazir, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Université Libre de Bruxelles - Hôpital Erasme</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Massimo Pandolfo, MD, PhD</last_name>
      <email>massimo.pandolfo@ulb.ac.be</email>
    </contact>
    <investigator>
      <last_name>Massimo Pandolfo, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Panum Institute</name>
      <address>
        <city>Copenhagen</city>
        <zip>2200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jorgen E Nielsen, MD, PhD</last_name>
      <phone>004535527816</phone>
      <email>jnielsen@imbg.ku.dk</email>
    </contact>
    <investigator>
      <last_name>Jorgen E Nielsen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kristin Husby Scheuer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU d'Angers</name>
      <address>
        <city>Angers</city>
        <zip>49000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Verny, MD</last_name>
      <phone>003241354613</phone>
      <email>chverny@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Christophe Verny, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cyril Goizet, MD, PhD</last_name>
      <email>cyril.goizet@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Cyril Goizet, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpitaux de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Odile Boespflug-Tanguy, MD, PhD</last_name>
      <phone>0033473448657</phone>
      <email>Odile.BOESPFLUG@inserm.u-clermont1.fr</email>
    </contact>
    <investigator>
      <last_name>Odile Boespflug-Tanguy, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Pollak, MD, PhD</last_name>
      <phone>0033476765791</phone>
      <email>pierre.pollak@ujf-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Philippe Azulay, MD, PhD</last_name>
      <phone>0033491386579</phone>
      <email>jean-philippe.azulay@mail.ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Philippe Azulay, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karine N'Guyen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Carémeau</name>
      <address>
        <city>Nîmes</city>
        <zip>30000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Labauge, MD, PhD</last_name>
      <phone>0033466683263</phone>
      <email>labauge@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Pierre Labauge, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Armand Trousseau</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Rodriguez, MD</last_name>
      <email>diana.rodriguez@trs.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Diana Rodriguez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pitié-Salpêtrière Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandra Dürr, MD, PhD</last_name>
      <phone>0033142162182</phone>
      <email>alexandra.durr@upmc.fr</email>
    </contact>
    <investigator>
      <last_name>Alexandra Dürr, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexis Brice, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bertrand Fontaine, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Charles Nicolle</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier Hannequin, MD, PhD</last_name>
      <phone>0033232888170</phone>
      <email>Didier.hannequin@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Didier Hannequin, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Purpan</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Calvas, MD, PhD</last_name>
      <email>calvas.p@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Patrick Calvas, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hadassah-Hebrew University Hospital</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Lossos, MD</last_name>
      <email>ALOS@hadassah.org.il</email>
    </contact>
    <investigator>
      <last_name>Alexander Lossos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dipartimento Di Scienze Neurologiche</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Filla, MD, PhD</last_name>
      <phone>00390817462476</phone>
      <email>afilla@unina.it</email>
    </contact>
    <investigator>
      <last_name>Alessandro Filla, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Molecular Medicine and Department of Neurosciences</name>
      <address>
        <city>Roma</city>
        <zip>00165</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enrico Bertini, MD, PhD</last_name>
      <phone>00390668592105</phone>
      <email>ebertini@tin.it</email>
    </contact>
    <investigator>
      <last_name>Enrico Bertini, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Filippo Santorelli, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Université Saint-Joseph</name>
      <address>
        <city>Beirut</city>
        <zip>1107 2180</zip>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>André Mégarbané, MD, PhD</last_name>
      <phone>009611614046</phone>
      <email>megarban@dm.net.lb</email>
    </contact>
    <investigator>
      <last_name>André Mégarbané, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Rabat</name>
      <address>
        <city>Rabat</city>
        <country>Morocco</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali Benomar, MD, PhD</last_name>
      <email>ali.benomar@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Ali Benomar, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Radboud University Nijmegen Medical Centre</name>
      <address>
        <city>Nijmegen</city>
        <zip>6500 HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Berry Kremer, MD</last_name>
      <email>h.kremer@neuro.umcn.nl</email>
    </contact>
    <investigator>
      <last_name>Berry Kremer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ullevål University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>407</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chantal ME Tallaksen, MD, PhD</last_name>
      <email>Chantal.Tallaksen@ulleval.no</email>
    </contact>
    <investigator>
      <last_name>Chantal Tallaksen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeanette Koht, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne Kjersti Erichsen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Porto</name>
      <address>
        <city>Porto</city>
        <zip>4150-180</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jorge Sequeiros, MD, PhD</last_name>
      <email>jsequeir@ibmc.up.pt</email>
    </contact>
    <investigator>
      <last_name>Jorge Sequeiros, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital San Sebastião</name>
      <address>
        <city>Santa Maria de Feira</city>
        <zip>4520-211</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Coutinho, MD, PhD</last_name>
      <phone>00351256362847</phone>
      <email>pcoutinho@hospitalfeira.min-saude.pt</email>
    </contact>
    <investigator>
      <last_name>Paula Coutinho, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>King Khalid University Hospital</name>
      <address>
        <city>Riyadh</city>
        <zip>11461</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mustapha AM Salih, MD</last_name>
      <email>mustapha@ksu.edu.sa</email>
    </contact>
    <investigator>
      <last_name>Mustapha AM Salih, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Centre of Serbia</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladimir Kostic, MD</last_name>
    </contact>
    <investigator>
      <last_name>Vladimir Kostic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vladana Spica, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marina Svetel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Habib Bourguiba</name>
      <address>
        <city>Sfax</city>
        <country>Tunisia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chokri Mhiri, MD</last_name>
      <email>chokri.mhiri@rns.tn</email>
    </contact>
    <investigator>
      <last_name>Chokri Mhiri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amir Boukhris, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nizar Elleuch, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Free and University College Medical School</name>
      <address>
        <city>London</city>
        <zip>NW3 2PF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas T Warner, MD, PhD</last_name>
      <email>t.warner@medsch.ucl.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Thomas T Warner, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The National Hospital</name>
      <address>
        <city>London</city>
        <zip>WC1N 3BG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas W Wood, MD, PhD</last_name>
      <phone>00442078373611</phone>
      <email>nwood@ion.ucl.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Nicholas W Wood, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Algeria</country>
    <country>Belgium</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Lebanon</country>
    <country>Morocco</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Portugal</country>
    <country>Saudi Arabia</country>
    <country>Serbia</country>
    <country>Tunisia</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.inserm.fr</url>
  </link>
  <results_reference>
    <citation>Moreira MC, Klur S, Watanabe M, Németh AH, Le Ber I, Moniz JC, Tranchant C, Aubourg P, Tazir M, Schöls L, Pandolfo M, Schulz JB, Pouget J, Calvas P, Shizuka-Ikeda M, Shoji M, Tanaka M, Izatt L, Shaw CE, M'Zahem A, Dunne E, Bomont P, Benhassine T, Bouslam N, Stevanin G, Brice A, Guimarães J, Mendonça P, Barbot C, Coutinho P, Sequeiros J, Dürr A, Warter JM, Koenig M. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat Genet. 2004 Mar;36(3):225-7. Epub 2004 Feb 8.</citation>
    <PMID>14770181</PMID>
  </results_reference>
  <results_reference>
    <citation>Le Ber I, Bouslam N, Rivaud-Péchoux S, Guimarães J, Benomar A, Chamayou C, Goizet C, Moreira MC, Klur S, Yahyaoui M, Agid Y, Koenig M, Stevanin G, Brice A, Dürr A. Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients. Brain. 2004 Apr;127(Pt 4):759-67. Epub 2004 Jan 21.</citation>
    <PMID>14736755</PMID>
  </results_reference>
  <results_reference>
    <citation>Le Ber I, Moreira MC, Rivaud-Péchoux S, Chamayou C, Ochsner F, Kuntzer T, Tardieu M, Saïd G, Habert MO, Demarquay G, Tannier C, Beis JM, Brice A, Koenig M, Dürr A. Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies. Brain. 2003 Dec;126(Pt 12):2761-72. Epub 2003 Sep 23.</citation>
    <PMID>14506070</PMID>
  </results_reference>
  <results_reference>
    <citation>Le Ber I, Camuzat A, Castelnovo G, Azulay JP, Genton P, Gastaut JL, Broglin D, Labauge P, Brice A, Durr A. Prevalence of dentatorubral-pallidoluysian atrophy in a large series of white patients with cerebellar ataxia. Arch Neurol. 2003 Aug;60(8):1097-9.</citation>
    <PMID>12925365</PMID>
  </results_reference>
  <results_reference>
    <citation>Bouslam N, Benomar A, Azzedine H, Bouhouche A, Namekawa M, Klebe S, Charon C, Durr A, Ruberg M, Brice A, Yahyaoui M, Stevanin G. Mapping of a new form of pure autosomal recessive spastic paraplegia (SPG28). Ann Neurol. 2005 Apr;57(4):567-71.</citation>
    <PMID>15786464</PMID>
  </results_reference>
  <results_reference>
    <citation>Dürr A, Camuzat A, Colin E, Tallaksen C, Hannequin D, Coutinho P, Fontaine B, Rossi A, Gil R, Rousselle C, Ruberg M, Stevanin G, Brice A. Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. Arch Neurol. 2004 Dec;61(12):1867-72.</citation>
    <PMID>15596607</PMID>
  </results_reference>
  <results_reference>
    <citation>Stevanin G, Durr A, Dussert C, Penet C, Brice A. Mutations in the FGF14 gene are not a major cause of spinocerebellar ataxia in Caucasians. Neurology. 2004 Sep 14;63(5):936.</citation>
    <PMID>15365159</PMID>
  </results_reference>
  <results_reference>
    <citation>Stevanin G, Hahn V, Lohmann E, Bouslam N, Gouttard M, Soumphonphakdy C, Welter ML, Ollagnon-Roman E, Lemainque A, Ruberg M, Brice A, Durr A. Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. Arch Neurol. 2004 Aug;61(8):1242-8.</citation>
    <PMID>15313841</PMID>
  </results_reference>
  <results_reference>
    <citation>Stevanin G, Bouslam N, Thobois S, Azzedine H, Ravaux L, Boland A, Schalling M, Broussolle E, Dürr A, Brice A. Spinocerebellar ataxia with sensory neuropathy (SCA25) maps to chromosome 2p. Ann Neurol. 2004 Jan;55(1):97-104.</citation>
    <PMID>14705117</PMID>
  </results_reference>
  <results_reference>
    <citation>Tallaksen CM, Guichart-Gomez E, Verpillat P, Hahn-Barma V, Ruberg M, Fontaine B, Brice A, Dubois B, Durr A. Subtle cognitive impairment but no dementia in patients with spastin mutations. Arch Neurol. 2003 Aug;60(8):1113-8.</citation>
    <PMID>12925368</PMID>
  </results_reference>
  <results_reference>
    <citation>Fernet M, Gribaa M, Salih MA, Seidahmed MZ, Hall J, Koenig M. Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder. Hum Mol Genet. 2005 Jan 15;14(2):307-18. Epub 2004 Dec 1.</citation>
    <PMID>15574463</PMID>
  </results_reference>
  <results_reference>
    <citation>Stevanin G, Durr A, Benammar N, Brice A. Spinocerebellar ataxia with mental retardation (SCA13). Cerebellum. 2005;4(1):43-6. Review.</citation>
    <PMID>15895558</PMID>
  </results_reference>
  <results_reference>
    <citation>Stevanin G, Broussolle E, Streichenberger N, Kopp N, Brice A, Durr A. Spinocerebellar ataxia with sensory neuropathy (SCA25). Cerebellum. 2005;4(1):58-61.</citation>
    <PMID>15895562</PMID>
  </results_reference>
  <results_reference>
    <citation>Klebe S, Durr A, Rentschler A, Hahn-Barma V, Abele M, Bouslam N, Schöls L, Jedynak P, Forlani S, Denis E, Dussert C, Agid Y, Bauer P, Globas C, Wüllner U, Brice A, Riess O, Stevanin G. New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. Ann Neurol. 2005 Nov;58(5):720-9.</citation>
    <PMID>16193476</PMID>
  </results_reference>
  <results_reference>
    <citation>Latouche M, Fragner P, Martin E, El Hachimi KH, Zander C, Sittler A, Ruberg M, Brice A, Stevanin G. Polyglutamine and polyalanine expansions in ataxin7 result in different types of aggregation and levels of toxicity. Mol Cell Neurosci. 2006 Mar;31(3):438-45. Epub 2005 Dec 1.</citation>
    <PMID>16325416</PMID>
  </results_reference>
  <results_reference>
    <citation>Namekawa M, Ribai P, Nelson I, Forlani S, Fellmann F, Goizet C, Depienne C, Stevanin G, Ruberg M, Dürr A, Brice A. SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years. Neurology. 2006 Jan 10;66(1):112-4.</citation>
    <PMID>16401858</PMID>
  </results_reference>
  <results_reference>
    <citation>van de Warrenburg BP, Hendriks H, Dürr A, van Zuijlen MC, Stevanin G, Camuzat A, Sinke RJ, Brice A, Kremer BP. Age at onset variance analysis in spinocerebellar ataxias: a study in a Dutch-French cohort. Ann Neurol. 2005 Apr;57(4):505-12.</citation>
    <PMID>15747371</PMID>
  </results_reference>
  <results_reference>
    <citation>Biancalana V, Toft M, Le Ber I, Tison F, Scherrer E, Thibodeau S, Mandel JL, Brice A, Farrer MJ, Dürr A. FMR1 premutations associated with fragile X-associated tremor/ataxia syndrome in multiple system atrophy. Arch Neurol. 2005 Jun;62(6):962-6.</citation>
    <PMID>15956167</PMID>
  </results_reference>
  <results_reference>
    <citation>Ribaï P, Stevanin G, Trefouret S, Nelson I, Soumphonphakdy C, Pouget J, Dürr A, Brice A. Extension of the SPG26 phenotype in a Spanish family and refinement of its locus on chromosome 12. Eletter, Journal of Medical Genetics 42(1):80-82, 2005.</citation>
  </results_reference>
  <results_reference>
    <citation>Elleuch N, Depienne C, Benomar A, Hernandez AM, Ferrer X, Fontaine B, Grid D, Tallaksen CM, Zemmouri R, Stevanin G, Durr A, Brice A. Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia. Neurology. 2006 Mar 14;66(5):654-9.</citation>
    <PMID>16534102</PMID>
  </results_reference>
  <results_reference>
    <citation>Le Ber I, Rivaud-Péchoux S, Brice A, Dürr A. [Autosomal recessive cerebellar ataxias with oculomotor apraxia]. Rev Neurol (Paris). 2006 Feb;162(2):177-84. Review. French.</citation>
    <PMID>16518257</PMID>
  </results_reference>
  <results_reference>
    <citation>Namekawa M, Nelson I, Ribai P, Dürr A, Denis E, Stevanin G, Ruberg M, Brice A. A founder effect and mutational hot spots may contribute to the most frequent mutations in the SPG3A gene. Neurogenetics. 2006 May;7(2):131-2. Epub 2006 Apr 13.</citation>
    <PMID>16612642</PMID>
  </results_reference>
  <results_reference>
    <citation>Lossos A, Stevanin G, Meiner V, Argov Z, Bouslam N, Newman JP, Gomori JM, Klebe S, Lerer I, Elleuch N, Silverstein S, Durr A, Abramsky O, Ben-Nariah Z, Brice A. Hereditary spastic paraplegia with thin corpus callosum: reduction of the SPG11 interval and evidence for further genetic heterogeneity. Arch Neurol. 2006 May;63(5):756-60.</citation>
    <PMID>16682547</PMID>
  </results_reference>
  <results_reference>
    <citation>Klebe S, Azzedine H, Durr A, Bastien P, Bouslam N, Elleuch N, Forlani S, Charon C, Koenig M, Melki J, Brice A, Stevanin G. Autosomal recessive spastic paraplegia (SPG30) with mild ataxia and sensory neuropathy maps to chromosome 2q37.3. Brain. 2006 Jun;129(Pt 6):1456-62. Epub 2006 Jan 24.</citation>
    <PMID>16434418</PMID>
  </results_reference>
  <results_reference>
    <citation>Ribai P, Stevanin G, Bouslam N, Pontier B, Nelson I, Fontaine B, Dussert C, Charon C, Durr A, Brice A. A new phenotype linked to SPG27 and refinement of the critical region on chromosome. J Neurol. 2006 Jun;253(6):714-9. Epub 2006 Mar 6.</citation>
    <PMID>16511635</PMID>
  </results_reference>
  <results_reference>
    <citation>Le Ber I, Clot F, Vercueil L, Camuzat A, Viémont M, Benamar N, De Liège P, Ouvrard-Hernandez AM, Pollak P, Stevanin G, Brice A, Dürr A. Predominant dystonia with marked cerebellar atrophy: a rare phenotype in familial dystonia. Neurology. 2006 Nov 28;67(10):1769-73.</citation>
    <PMID>17130408</PMID>
  </results_reference>
  <results_reference>
    <citation>Stevanin G, Montagna G, Azzedine H, Valente EM, Durr A, Scarano V, Bouslam N, Cassandrini D, Denora PS, Criscuolo C, Belarbi S, Orlacchio A, Jonveaux P, Silvestri G, Hernandez AM, De Michele G, Tazir M, Mariotti C, Brockmann K, Malandrini A, van der Knapp MS, Neri M, Tonekaboni H, Melone MA, Tessa A, Dotti MT, Tosetti M, Pauri F, Federico A, Casali C, Cruz VT, Loureiro JL, Zara F, Forlani S, Bertini E, Coutinho P, Filla A, Brice A, Santorelli FM. Spastic paraplegia with thin corpus callosum: description of 20 new families, refinement of the SPG11 locus, candidate gene analysis and evidence of genetic heterogeneity. Neurogenetics. 2006 Jul;7(3):149-56. Epub 2006 May 13.</citation>
    <PMID>16699786</PMID>
  </results_reference>
  <results_reference>
    <citation>Klebe S, Lacour A, Durr A, Stojkovic T, Depienne C, Forlani S, Poea-Guyon S, Vuillaume I, Sablonniere B, Vermersch P, Brice A, Stevanin G. NIPA1 (SPG6) mutations are a rare cause of autosomal dominant spastic paraplegia in Europe. Neurogenetics. 2007 Apr;8(2):155-7. Epub 2007 Jan 5.</citation>
    <PMID>17205300</PMID>
  </results_reference>
  <results_reference>
    <citation>Bouslam N, Bouhouche A, Benomar A, Hanein S, Klebe S, Azzedine H, Di Giandomenico S, Boland-Augé A, Santorelli FM, Durr A, Brice A, Yahyaoui M, Stevanin G. A novel locus for autosomal recessive spastic ataxia on chromosome 17p. Hum Genet. 2007 May;121(3-4):413-20. Epub 2007 Feb 2.</citation>
    <PMID>17273843</PMID>
  </results_reference>
  <results_reference>
    <citation>Stevanin G, Santorelli FM, Azzedine H, Coutinho P, Chomilier J, Denora PS, Martin E, Ouvrard-Hernandez AM, Tessa A, Bouslam N, Lossos A, Charles P, Loureiro JL, Elleuch N, Confavreux C, Cruz VT, Ruberg M, Leguern E, Grid D, Tazir M, Fontaine B, Filla A, Bertini E, Durr A, Brice A. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet. 2007 Mar;39(3):366-72. Epub 2007 Feb 18.</citation>
    <PMID>17322883</PMID>
  </results_reference>
  <results_reference>
    <citation>Latouche M, Lasbleiz C, Martin E, Monnier V, Debeir T, Mouatt-Prigent A, Muriel MP, Morel L, Ruberg M, Brice A, Stevanin G, Tricoire H. A conditional pan-neuronal Drosophila model of spinocerebellar ataxia 7 with a reversible adult phenotype suitable for identifying modifier genes. J Neurosci. 2007 Mar 7;27(10):2483-92.</citation>
    <PMID>17344386</PMID>
  </results_reference>
  <results_reference>
    <citation>Klebe S, Durr A, Bouslam N, Grid D, Paternotte C, Depienne C, Hanein S, Bouhouche A, Elleuch N, Azzedine H, Poea-Guyon S, Forlani S, Denis E, Charon C, Hazan J, Brice A, Stevanin G. Spastic paraplegia 5: Locus refinement, candidate gene analysis and clinical description. Am J Med Genet B Neuropsychiatr Genet. 2007 Oct 5;144B(7):854-61.</citation>
    <PMID>17503452</PMID>
  </results_reference>
  <results_reference>
    <citation>Stevanin G, Paternotte C, Coutinho P, Klebe S, Elleuch N, Loureiro JL, Denis E, Cruz VT, Dürr A, Prud'homme JF, Weissenbach J, Brice A, Hazan J. A new locus for autosomal recessive spastic paraplegia (SPG32) on chromosome 14q12-q21. Neurology. 2007 May 22;68(21):1837-40.</citation>
    <PMID>17515546</PMID>
  </results_reference>
  <results_reference>
    <citation>Namekawa M, Muriel MP, Janer A, Latouche M, Dauphin A, Debeir T, Martin E, Duyckaerts C, Prigent A, Depienne C, Sittler A, Brice A, Ruberg M. Mutations in the SPG3A gene encoding the GTPase atlastin interfere with vesicle trafficking in the ER/Golgi interface and Golgi morphogenesis. Mol Cell Neurosci. 2007 May;35(1):1-13. Epub 2007 Jan 26.</citation>
    <PMID>17321752</PMID>
  </results_reference>
  <results_reference>
    <citation>Stevanin G, Azzedine H, Denora P, Boukhris A, Tazir M, Lossos A, Rosa AL, Lerer I, Hamri A, Alegria P, Loureiro J, Tada M, Hannequin D, Anheim M, Goizet C, Gonzalez-Martinez V, Le Ber I, Forlani S, Iwabuchi K, Meiner V, Uyanik G, Erichsen AK, Feki I, Pasquier F, Belarbi S, Cruz VT, Depienne C, Truchetto J, Garrigues G, Tallaksen C, Tranchant C, Nishizawa M, Vale J, Coutinho P, Santorelli FM, Mhiri C, Brice A, Durr A; SPATAX consortium. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain. 2008 Mar;131(Pt 3):772-84. Epub 2007 Dec 13.</citation>
    <PMID>18079167</PMID>
  </results_reference>
  <results_reference>
    <citation>Boukhris A, Feki I, Denis E, Miladi MI, Brice A, Mhiri C, Stevanin G. Spastic paraplegia 15: linkage and clinical description of three Tunisian families. Mov Disord. 2008 Feb 15;23(3):429-33.</citation>
    <PMID>18098276</PMID>
  </results_reference>
  <results_reference>
    <citation>Boukhris A, Stevanin G, Feki I, Denis E, Elleuch N, Miladi MI, Truchetto J, Denora P, Belal S, Mhiri C, Brice A. Hereditary spastic paraplegia with mental impairment and thin corpus callosum in Tunisia: SPG11, SPG15, and further genetic heterogeneity. Arch Neurol. 2008 Mar;65(3):393-402. doi: 10.1001/archneur.65.3.393.</citation>
    <PMID>18332254</PMID>
  </results_reference>
  <results_reference>
    <citation>Hanein S, Martin E, Boukhris A, Byrne P, Goizet C, Hamri A, Benomar A, Lossos A, Denora P, Fernandez J, Elleuch N, Forlani S, Durr A, Feki I, Hutchinson M, Santorelli FM, Mhiri C, Brice A, Stevanin G. Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome. Am J Hum Genet. 2008 Apr;82(4):992-1002. doi: 10.1016/j.ajhg.2008.03.004.</citation>
    <PMID>18394578</PMID>
  </results_reference>
  <results_reference>
    <citation>Denora PS, Schlesinger D, Casali C, Kok F, Tessa A, Boukhris A, Azzedine H, Dotti MT, Bruno C, Truchetto J, Biancheri R, Fedirko E, Di Rocco M, Bueno C, Malandrini A, Battini R, Sickl E, de Leva MF, Boespflug-Tanguy O, Silvestri G, Simonati A, Said E, Ferbert A, Criscuolo C, Heinimann K, Modoni A, Weber P, Palmeri S, Plasilova M, Pauri F, Cassandrini D, Battisti C, Pini A, Tosetti M, Hauser E, Masciullo M, Di Fabio R, Piccolo F, Denis E, Cioni G, Massa R, Della Giustina E, Calabrese O, Melone MA, De Michele G, Federico A, Bertini E, Durr A, Brockmann K, van der Knaap MS, Zatz M, Filla A, Brice A, Stevanin G, Santorelli FM. Screening of ARHSP-TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion. Hum Mutat. 2009 Mar;30(3):E500-19. doi: 10.1002/humu.20945.</citation>
    <PMID>19105190</PMID>
  </results_reference>
  <results_reference>
    <citation>Denora PS, Muglia M, Casali C, Truchetto J, Silvestri G, Messina D, Boukrhis A, Magariello A, Modoni A, Masciullo M, Malandrini A, Morelli M, de Leva MF, Villanova M, Giugni E, Citrigno L, Rizza T, Federico A, Pierallini A, Quattrone A, Filla A, Brice A, Stevanin G, Santorelli FM. Spastic paraplegia with thinning of the corpus callosum and white matter abnormalities: further mutations and relative frequency in ZFYVE26/SPG15 in the Italian population. J Neurol Sci. 2009 Feb 15;277(1-2):22-5. doi: 10.1016/j.jns.2008.09.039. Epub 2008 Dec 13.</citation>
    <PMID>19084844</PMID>
  </results_reference>
  <results_reference>
    <citation>Boukhris A, Stevanin G, Feki I, Denora P, Elleuch N, Miladi MI, Goizet C, Truchetto J, Belal S, Brice A, Mhiri C. Tunisian hereditary spastic paraplegias: clinical variability supported by genetic heterogeneity. Clin Genet. 2009 Jun;75(6):527-36. doi: 10.1111/j.1399-0004.2009.01176.x. Epub 2009 May 5.</citation>
    <PMID>19438933</PMID>
  </results_reference>
  <results_reference>
    <citation>Anheim M, Lagier-Tourenne C, Stevanin G, Fleury M, Durr A, Namer IJ, Denora P, Brice A, Mandel JL, Koenig M, Tranchant C. SPG11 spastic paraplegia. A new cause of juvenile parkinsonism. J Neurol. 2009 Jan;256(1):104-8. doi: 10.1007/s00415-009-0083-3. Epub 2009 Feb 9.</citation>
    <PMID>19224311</PMID>
  </results_reference>
  <results_reference>
    <citation>Goizet C, Boukhris A, Durr A, Beetz C, Truchetto J, Tesson C, Tsaousidou M, Forlani S, Guyant-Maréchal L, Fontaine B, Guimarães J, Isidor B, Chazouillères O, Wendum D, Grid D, Chevy F, Chinnery PF, Coutinho P, Azulay JP, Feki I, Mochel F, Wolf C, Mhiri C, Crosby A, Brice A, Stevanin G. CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5. Brain. 2009 Jun;132(Pt 6):1589-600. doi: 10.1093/brain/awp073. Epub 2009 May 12.</citation>
    <PMID>19439420</PMID>
  </results_reference>
  <results_reference>
    <citation>Goizet C, Boukhris A, Maltete D, Guyant-Maréchal L, Truchetto J, Mundwiller E, Hanein S, Jonveaux P, Roelens F, Loureiro J, Godet E, Forlani S, Melki J, Auer-Grumbach M, Fernandez JC, Martin-Hardy P, Sibon I, Sole G, Orignac I, Mhiri C, Coutinho P, Durr A, Brice A, Stevanin G. SPG15 is the second most common cause of hereditary spastic paraplegia with thin corpus callosum. Neurology. 2009 Oct 6;73(14):1111-9. doi: 10.1212/WNL.0b013e3181bacf59.</citation>
    <PMID>19805727</PMID>
  </results_reference>
  <results_reference>
    <citation>Anheim M, Monga B, Fleury M, Charles P, Barbot C, Salih M, Delaunoy JP, Fritsch M, Arning L, Synofzik M, Schöls L, Sequeiros J, Goizet C, Marelli C, Le Ber I, Koht J, Gazulla J, De Bleecker J, Mukhtar M, Drouot N, Ali-Pacha L, Benhassine T, Chbicheb M, M'Zahem A, Hamri A, Chabrol B, Pouget J, Murphy R, Watanabe M, Coutinho P, Tazir M, Durr A, Brice A, Tranchant C, Koenig M. Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain. 2009 Oct;132(Pt 10):2688-98. doi: 10.1093/brain/awp211. Epub 2009 Aug 20.</citation>
    <PMID>19696032</PMID>
  </results_reference>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2005</study_first_submitted>
  <study_first_submitted_qc>August 30, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2005</study_first_posted>
  <last_update_submitted>March 26, 2012</last_update_submitted>
  <last_update_submitted_qc>March 26, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 27, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cerebellar ataxias</keyword>
  <keyword>Spastic paraplegias</keyword>
  <keyword>Mutations spectrum</keyword>
  <keyword>Linkage studies</keyword>
  <keyword>Genetic counselling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ataxia</mesh_term>
    <mesh_term>Cerebellar Ataxia</mesh_term>
    <mesh_term>Muscle Spasticity</mesh_term>
    <mesh_term>Paraplegia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

